These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Retreatment effect of NPe6 photodynamic therapy on the normal primate macula. Nakashizuka T, Mori K, Hayashi N, Anzail K, Kanail K, Yoneya S, Moshfeghi DM, Peyman GA. Retina; 2001; 21(5):493-8. PubMed ID: 11642379 [Abstract] [Full Text] [Related]
4. Effects of photodynamic therapy using verteporfin on experimental choroidal neovascularization and normal retina and choroid up to 7 weeks after treatment. Husain D, Kramer M, Kenny AG, Michaud N, Flotte TJ, Gragoudas ES, Miller JW. Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2322-31. PubMed ID: 10476799 [Abstract] [Full Text] [Related]
5. Verteporfin photodynamic therapy retreatment of normal retina and choroid in the cynomolgus monkey. Reinke MH, Canakis C, Husain D, Michaud N, Flotte TJ, Gragoudas ES, Miller JW. Ophthalmology; 1999 Oct; 106(10):1915-23. PubMed ID: 10519585 [Abstract] [Full Text] [Related]
6. Photodynamic therapy of experimental choroidal neovascularization with a hydrophilic photosensitizer: mono-L-aspartyl chlorin e6. Mori K, Yoneya S, Anzail K, Kabasawa S, Sodeyama T, Peyman GA, Moshfeghi DM. Retina; 2001 Oct; 21(5):499-508. PubMed ID: 11642380 [Abstract] [Full Text] [Related]
7. Threshold power levels for NPe6 photodynamic therapy. Kazi AA, Peyman GA, Unal M, Khoobehi B, Yoneya S, Mori K, Moshfeghi D, Moshfeghi AA. Ophthalmic Surg Lasers; 2000 Oct; 31(2):136-42. PubMed ID: 10743925 [Abstract] [Full Text] [Related]
15. Photodynamic therapy of pigmented choroidal melanomas using a liposomal preparation of benzoporphyrin derivative. Young LH, Howard MA, Hu LK, Kim RY, Gragoudas ES. Arch Ophthalmol; 1996 Feb; 114(2):186-92. PubMed ID: 8573023 [Abstract] [Full Text] [Related]